AEON Biopharma, Inc.
General ticker "AEON" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.4M (TTM average)
AEON Biopharma, Inc. does not follow the US Stock Market performance with the rate: -9.3%.
Estimated limits based on current volatility of 6.7%: low 0.96$, high 1.09$
Short-term AEON quotes
Long-term AEON plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $65.85MM | $48.43MM | $348.09MM |
| Operating Income | $-65.85MM | $-48.43MM | $-348.09MM |
| Non-Operating Income | $10.21MM | $-4.13MM | $-36.55MM |
| R&D Expense | $25.73MM | $34.75MM | $33.05MM |
| Income(Loss) | $-55.64MM | $-52.56MM | $-384.63MM |
| Profit(Loss)* | $-55.64MM | $-52.56MM | $-384.63MM |
| Stockholders Equity | $-234.94MM | $-287.50MM | $-153.04MM |
| Assets | $6.44MM | $10.78MM | $6.84MM |
| Operating Cash Flow | $-28.43MM | $-35.58MM | $-47.83MM |
| Capital expenditure | $0.17MM | $0.31MM | $0.00MM |
| Investing Cash Flow | $-0.17MM | $-0.31MM | $0.00MM |
| Financing Cash Flow | $13.56MM | $40.51MM | $14.00MM |
| Earnings Per Share** | $-31.74 | $-27.26 | $-4.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.